Is Biostax Corp. (BTAX) a Buy, Sell, or Hold?
OTC : BTAX
Biostax Corp.
$0.0001 USD
$0 (0.0%)
- Volume
- 2.19K
- Average Volume
- 8
- Market Capitalization
- $7.87K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.01
Company Overview
OTC
Noreen Griffin
Biotechnology
Healthcare
BTAX
4
US
USD
Liquidity Metrics
-0.25
0.01
0.01
0.01
0.00
Sales & Valuation
-$
0.00
0.00
-0.02
0.00
Profitability
-$0.03
-$2.36M
0.00%
0.00%
67.11%
-6695.90%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
No financial score data available.
Key Metrics (TTM)
$1.11M
0.00
-0.52
0.01
67.11%
43.69%
-28291.79%
-5183.92%
0 days
Company Executives
| Name | Title |
|---|---|
| Noreen Griffin | Founder, Executive Vice President of Business Development & Chief Executive Officer |
| Kelly O'Brien Wilson | President |
| Robert Wilson | Vice President of Strategy & Director |
| Cynthia Douglas | Company Secretary |
| Joseph Fortunak | Vice President of Global Research & Development and Chemical Development |
| Glen A. Farmer | Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About Biostax Corp. (OTC:BTAX) Stock
Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition, advancement, and commercialization of various pharmaceutical and biotechnology solutions. A pivotal focus lies on Lodonal, their lead investigational drug candidate, designed as a once-daily immune system modulator aimed at managing both human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Beyond this primary drug, their portfolio encompasses several innovative programs. These include a Global Telehealth platform and an early-stage Medtech initiative leveraging blockchain and smart contract technologies to enhance the security and management of prescriptions and electronic health records. Furthermore, Biostax is developing JKB-122, an experimental small molecule that acts as a long-dur ... ation toll-like receptor 4 (TLR4) antagonist, intended for the treatment of autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Another compound they address is Low Dose Naltrexone, a formula believed to offer immune-modulating advantages pertinent to conditions such as cancer, chronic pain, autoimmune disorders, and anti-aging efforts. The company also pursues development efforts for addressing hyperphosphatemia. Biostax maintains a licensing agreement with Cytocom Inc. and underwent a corporate name change from Immune Therapeutics, Inc. to its current designation in October 2023. The company's operational base is located in Winter Park, Florida.
Frequently Asked Questions
-
What is the current Biostax Corp. (BTAX) stock price?
-
Biostax Corp.(OTC:BTAX) stock price is $0.0001 in the last trading session. During the trading session, BTAX stock reached the peak price of $0.0002 while $0.0001 was the lowest point it dropped to. The percentage change in BTAX stock occurred in the recent session was 0.0% while the dollar amount for the price change in BTAX stock was $0.
-
BTAX's industry and sector of operation?
-
The OTC listed BTAX is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of BTAX?
-
Noreen Griffin | Founder, Executive Vice President of Business Development & Chief Executive Officer
Kelly O'Brien Wilson | President
Robert Wilson | Vice President of Strategy & Director
Cynthia Douglas | Company Secretary
Joseph Fortunak | Vice President of Global Research & Development and Chemical Development -
How many employees does BTAX have?
-
Number of BTAX employees currently stands at 4. BTAX operates from 2431 Aloma Ave., Winter Park, FL 32804, US.
-
Link for BTAX official website?
-
Official Website of BTAX is: https://www.biostaxcorp.com
-
How do I contact BTAX?
-
BTAX could be contacted at phone #888 613 8802 and can also be accessed through its website. BTAX operates from 2431 Aloma Ave., Winter Park, FL 32804, US.
-
How many shares of BTAX are traded daily?
-
The average number of BTAX shares traded daily for last 3 months was 8.
-
What is the market cap of BTAX currently?
-
The market value of BTAX currently stands at $7.87K with its latest stock price at $0.0001